Natco Pharma reports consolidated net loss of Rs 50.50 crore in the March 2022 quarter

Sales rise 80.14% to Rs 596.80 crore

Net loss of Natco Pharma reported to Rs 50.50 crore in the quarter ended March 2022 as against net profit of Rs 53.00 crore during the previous quarter ended March 2021. Sales rose 80.14% to Rs 596.80 crore in the quarter ended March 2022 as against Rs 331.30 crore during the previous quarter ended March 2021.

For the full year,net profit declined 61.44% to Rs 170.00 crore in the year ended March 2022 as against Rs 440.90 crore during the previous year ended March 2021. Sales declined 5.23% to Rs 1944.80 crore in the year ended March 2022 as against Rs 2052.10 crore during the previous year ended March 2021.

ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales596.80331.30 80 1944.802052.10 -5 OPM %-3.1223.00 -13.5529.54 - PBDT-11.50101.10 PL 344.80696.50 -50 PBT-49.6070.70 PL 202.20579.60 -65 NP-50.5053.00 PL 170.00440.90 -61

Powered by Capital Market - Live News